Biophytis (BPTS) Financials

$7.03

$0.12 (1.74%)

As on 27-Jun-2024 09:30EDT

Market cap

$3 Mln

Revenue (TTM)

$-- Mln

P/E Ratio

--

P/B Ratio

2.3

Div. Yield

0 %

Annual
Quarterly

Income Statement (€ Mln)	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
Operating Revenue	--	--	--	--	--	--
Cost of Revenue	0.80	0.48	0.31	0.28	0.26	0.23
Gross Profit	-0.80	-0.48	-0.31	-0.28	-0.26	-0.23
Operating Expenses	15.09	23.27	26.82	13.94	15.68	13.86
Operating Profit (EBIT)	-15.89	-23.27	-26.82	-13.94	-15.68	-13.86
Other Income	--	--	--	--	--	--
Profit before Tax	-18.59	-24.22	-31.25	-17.05	-17.82	-14.06
Provision for Tax	-1.56	-1.52	2.28	4.37	-0.03	-0.07
Profit after Tax (Net Income)	-17.03	-22.70	-33.53	-21.43	-17.79	-13.99
Minority Interest	--	--	0.00	-0.03	-0.03	-0.03
Consolidated Profit	--	-24.22	-31.25	-17.05	-17.79	-13.99

Liabilities (€ Mln)	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
Shareholder's Funds	-3.88	-1.88	5.74	6.86	-7.50	7.04
Minority Interest	--	--	--	--	--	--
Non-Current Liabilities	3.48	4.55	7.41	2.02	5.54	6.57
Current Liabilities	12.37	19.35	23.14	18.36	19.66	8.28
Total Liabilities	11.94	21.99	36.26	27.21	17.67	21.86

Assets (€ Mln)	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
Non-Current Assets	3.09	3.41	4.57	3.20	2.97	2.51
Current Assets	8.85	18.58	31.69	24.01	14.71	19.36
Total Assets	11.94	21.99	36.26	27.21	17.67	21.86
Total Debt*	8.27	12.13	15.38	9.10	15.25	8.20
Net Current Assets	-3.52	-0.77	8.55	5.65	-4.95	11.07

Cashflow (€ Mln)	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
Cash From Operating Activities	-13.33	-18.99	-23.80	-9.86	-15.27	-12.06
Cash Flow from Investing Activities	--	-0.02	12.16	-12.71	-0.28	-0.10
Cash from Financing Activities	7.49	6.13	29.72	22.07	7.50	6.77
Net Cash Inflow / Outflow	--	--	--	--	--	--

Financials Ratios	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
Adjusted EPS (€)	--	--	--	--	--	--
Cash EPS (€)	--	--	--	--	--	--
Adjusted Book Value (€)	--	--	--	--	--	--
Dividend per Share (€)	--	--	--	--	--	--
Cash Flow per Share (€)	--	--	--	--	--	--
Free Cash Flow per Share (€)	--	--	--	--	--	--

Profitability Ratios	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
ROCE (%)	-232.66	-144.74	-180.87	-180.77	-154.77	-74.67
ROE (%)	591.18	-1,176.52	-532.16	6,781.01	7,767.69	-99.01
ROA (%)	-100.38	-77.92	-105.64	-95.49	-89.99	-58.51
EBIT Margin (%)	--	--	--	--	--	--
Net Margin (%)	--	--	--	--	--	--
Cash Profit Margin (%)	--	--	--	--	--	--

Growth Ratios	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
Revenue Growth (%)	--	--	--	--	--	--
EBIT Growth (%)	31.70	13.21	-92.33	11.10	-13.14	-40.41
Net Profit Growth (%)	24.98	32.31	-56.46	-20.46	-27.18	-22.60
EPS Growth (%)	--	--	--	--	--	--
Book Value Growth (%)	--	--	--	--	--	--

Solvency Ratios	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
Debt to Equity	-2.13	-6.45	2.68	1.33	-2.03	1.17
Short term debt to equity ratio	-1.29	-4.13	1.58	1.06	-1.31	0.26
Current Ratio	0.72	0.96	1.37	1.31	0.75	2.34
Quick Ratio	--	0.88	1.40	1.31	0.75	2.36
Interest Coverage	-12.71	-14.57	-6.05	-3.19	-6.21	-74.92

Operating Efficiency Ratios	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
Debtors to sales (%)	--	--	--	--	--	--
Asset Turnover	--	--	--	--	--	--
Receivable days	--	--	--	--	--	--
Inventory Days	715.94	326.39	-399.31	48.92	-87.13	-275.14
Payable days	2,804.65	5,488.56	9,155.33	10,338.53	8,874.74	5,847.22
Cash Conversion Cycle	--	--	--	--	--	--